✦ LIBER ✦

MP-20.24: Tolterodine extended release (TER) and/or Tamsulosin (TAM) in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of prostate size

✍ Scribed by C.G. Roehrborn; S.A. Kaplan; J.S. Jones; W. Steers; J.T. Wang; T. Bavendam; Z. Guan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-20.23: Tolterodine extended release (

✍ C.G. Roehrborn; S.A. Kaplan; S.R. Kraus; J.T. Wang; T. Bavendam; Z. Guan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Tolterodine Extended Release With or Wit

✍ Claus G. Roehrborn; Steven A. Kaplan; J. Stephen Jones; Joseph T. Wang; Tamara B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Editorial Comment on: Tolterodine Extend

✍ Daniele Porru 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Editorial Comment on: Tolterodine Extend

✍ Jean Jacques Wyndaele 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Extended-release tolterodine with or wit

✍ Steven A. Kaplan; Claus G. Roehrborn; Michael Chancellor; Martin Carlsson; Tamar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

1007 EFFECTS OF TOLTERODINE EXTENDED REL

✍ Kaplan, S.A.; Rovner, E.S.; Sussman, P.O.; Kreder, K.; Kraus, S.; Carlsson, M.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 323 KB